Trading Signals: ATRA Stock Price Prediction and Forecast (Mon. Oct. 26, 2015 - Wed. Sep. 14, 2022)(Atara Biotherapeutics, Inc.)
| ATRA latest price $22.2900 (7.16%) ($20.7600 - $22.5500) on Thu. Nov. 19, 2020. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 4.25% (three month average) | RSI | 88 | Latest Price | $22.2900(7.16%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | ATRA advances 4.3% a day on average for past five trading days. | Weekly Trend | ATRA advances 24.2% a week on average for past two weeks. | Market Behavior | Growth stock rally for large cap. Growth stock rally for small cap. | Correlated ETFs | Broad market will support ATRA advance at 0% a week (0% probability) XBI(52%) ARKG(45%) ARKK(44%) IBB(44%) IWO(43%) | Factors Impacting ATRA price | ATRA will decline at least -2.125% in a week (0% probabilities). VIXM(-31%) VXX(-25%) UNG(-11%) UUP(-9%) TLT(-7%) | Explanation | The rally is not sustainable and not supported by the broad market. | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -2.125% (StdDev 4.25%) | Hourly BBV | 1.3 () | Intraday Trend | 0% | | | |
|
5 Day Moving Average | $20.21(10.29%) | 10 Day Moving Average | $18.01(23.76%) | 20 Day Moving Average | $15.92(40.01%) | To recent high | 0% | To recent low | 77.6% | Market Cap | $1.656b | | | | Atara Biotherapeutics, Inc. operates as a clinical stage company, which engages in the development of novel therapeutics for patients with cancer, autoimmune, and viral diseases. Its pipeline includes Tab-cel, ATA188, ATA2271/ATA3271, and ATA3219. The company was founded by Isaac E. Ciechanover on August 22, 2012 and is headquartered in South San Francisco, CA. |